Option chain shows key data for Better Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Better Therapeutics.

Better Therapeutics (OTC:BTTX) Stock, Option Chain

Better Therapeutics

Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ADBE

ADTH

ALTG

AMPS

AQST

BFRI

BLND

BLNK

BTTX

CDLX

CISS

COMM

DESP

DRCT

EVCM

GRPN

HCMA

IMRX

JTAI

KOPN

LSDI

MDGL

MNTK

MSTR

PRST

SANM

SECO

SHCO

SMAR

ULTA

VERB

XELB

Shares of  Jabil Inc. (NYSE: JBL) fell sharply during Friday’s session after the company reported financial second-quarter results and issued FY25 guidance below estimates.

Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Earnings

Eurozone

Commodities

Global

HIBB

U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 100 points on Friday.

Following the market opening Friday, the Dow traded down 0.28% to 38,797.24 while the NASDAQ fell 0.67% to 16,020.07. The S&amp;P 500 also fell, dropping, 0.58% to 5,120.59.

Nasdaq Down Over 100 Points; Hibbett Reports Downbeat Sales

Pre-Market Outlook

ADIL

ALCE

BREA

KUKE

TBIO

TSVT

Shares of  Cardlytics, Inc. (NASDAQ: CDLX) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter earnings.

Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket

BETTER THERAPEUTICS INC by Better Therapeutics, Inc.

Better Therapeutics Inc

Lake Street

Chardan Capital

Screenshot 2024-02-22 at 11.51.01 PM

Biotech

General

Better Therapeutics Follows Up Wins Including FDA Authorization For AspyreRx In 2023 With Securing FDA Breakthrough Device Designation Targeting Advanced Liver Disease

Comments

Better Therapeutics

Better Therapeutics (BTTX) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell